drugset / Trial / NCT01370707
A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the efficacy and safety fo CJ-30001/CJ-30002.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-07
- Completion
- 2012-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CJ-30002 | Unknown | 1500 mg | — |
| Subject | CJ30001 | Unknown | 0.6 mg | — |
| Subject | CJ30001 | Unknown | 0.9 mg | — |
| Comparator | Metformin | Small molecule | 1000 mg | — |
| Comparator | Metformin | Small molecule | 1500 mg | — |